Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase 1 2Phase 1/2 1

Status

Completed 11Recruiting 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Urothelial Carcinoma Ureter 1Peritoneal Neoplasms 1Peritoneal Diseases 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Cyclophosphamide 21fludarabine 17Specimen Handling 13Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 9Radiotherapy 7Cisplatin 7fludarabine phosphate 5Injections 5tislelizumab 4daratumumab 4Rituximab 4Paclitaxel 4Ipilimumab 4Interleukin-2 4Immune Checkpoint Inhibitors 4Gemcitabine 4Fluorouracil 4Drug Therapy 4Doxorubicin 4Dexamethasone 4Carboplatin 4Biopsy 4venetoclax 3toripalimab 3X-Rays 3Radiosurgery 3Platinum 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Mitomycin × Clear all
NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Not yet recruiting
24 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

NCT05979909 2023-08-07

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

McMaster University

Phase 1 Not yet recruiting
40 enrolled
Genitourinary

Urothelial Carcinoma Ureter

Data powered by HemOnc (CC BY 4.0) Colophon âš¡